Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,532 | 91 | 96.2% |
| Education | $61.00 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $323.77 | 20 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $251.66 | 13 | $0 (2023) |
| Astellas Pharma US Inc | $134.57 | 6 | $0 (2023) |
| Novo Nordisk Inc | $116.35 | 7 | $0 (2022) |
| Merck Sharp & Dohme LLC | $102.08 | 6 | $0 (2023) |
| PFIZER INC. | $67.80 | 4 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $65.03 | 4 | $0 (2024) |
| EISAI INC. | $59.22 | 4 | $0 (2022) |
| Orexo US, Inc. | $47.43 | 3 | $0 (2021) |
| Allergan, Inc. | $45.56 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.82 | 4 | AstraZeneca Pharmaceuticals LP ($36.15) |
| 2023 | $318.99 | 14 | AbbVie Inc. ($81.76) |
| 2022 | $441.78 | 23 | Supernus Pharmaceuticals, Inc. ($160.04) |
| 2021 | $446.73 | 29 | AbbVie Inc. ($165.99) |
| 2020 | $85.88 | 6 | Allergan, Inc. ($45.56) |
| 2019 | $76.90 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($16.94) |
| 2018 | $67.62 | 5 | Astellas Pharma US Inc ($29.84) |
| 2017 | $86.93 | 6 | Astellas Pharma US Inc ($28.66) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Respiratory | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Diabetes Care | ||||||
| 10/19/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $61.00 | General |
| 07/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Biological | ||||||
| 07/06/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.28 | General |
| Category: PSYCHOLOGY | ||||||
| 03/09/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: PSYCHOLOGY | ||||||
| 02/02/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $22.38 | General |
| Category: PSYCHOLOGY | ||||||
| 01/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: INSOMNIA | ||||||
| 12/15/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: PSYCHOLOGY | ||||||
| 11/22/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: PSYCHOLOGY | ||||||
| 11/09/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| Category: PSYCHOLOGY | ||||||
| 10/14/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $24.11 | General |
| Category: PSYCHOLOGY | ||||||
| 10/13/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Cardiovascular | ||||||
| 09/15/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: PSYCHOLOGY | ||||||
| 09/15/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: PSYCHOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 775 | 912 | $94,935 | $63,710 |
| 2022 | 9 | 574 | 689 | $78,295 | $52,386 |
| 2021 | 11 | 572 | 710 | $82,062 | $54,805 |
| 2020 | 8 | 378 | 485 | $65,830 | $40,143 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 148 | 148 | $29,600 | $19,345 | 65.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 100 | $13,015 | $9,104 | 69.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 157 | $14,155 | $8,811 | 62.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 118 | 120 | $10,200 | $7,858 | 77.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 28 | 37 | $9,250 | $7,075 | 76.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 38 | $7,030 | $4,969 | 70.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 67 | $5,040 | $2,657 | 52.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 90 | 90 | $2,250 | $1,667 | 74.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 86 | 86 | $2,150 | $1,593 | 74.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 47 | $705.00 | $394.80 | 56.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 22 | $1,540 | $237.20 | 15.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 119 | 119 | $23,800 | $15,932 | 66.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 158 | 158 | $13,430 | $10,016 | 74.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 102 | $13,260 | $9,259 | 69.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 147 | $13,230 | $8,127 | 61.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 27 | 27 | $6,750 | $5,151 | 76.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 21 | $3,950 | $2,633 | 66.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 15 | 22 | $1,655 | $870.28 | 52.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 55 | 78 | $1,170 | $230.67 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 15 | $1,050 | $167.50 | 16.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 147 | 147 | $29,400 | $20,227 | 68.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 156 | $14,040 | $10,158 | 72.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 117 | $15,210 | $8,346 | 54.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 24 | 32 | $8,000 | $6,400 | 80.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 57 | 57 | $4,845 | $3,531 | 72.9% |
About Dr. Mary Scanlon, DO
Dr. Mary Scanlon, DO is a Family Medicine healthcare provider based in Lake Worth, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245240548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Scanlon, DO has received a total of $1,593 in payments from pharmaceutical and medical device companies, with $67.82 received in 2024. These payments were reported across 92 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,532).
As a Medicare-enrolled provider, Scanlon has provided services to 2,299 Medicare beneficiaries, totaling 2,796 services with total Medicare billing of $211,044. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lake Worth, FL
- Active Since 08/09/2006
- Last Updated 05/04/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245240548
Products in Payments
- QELBREE (Drug) $222.12
- UBRELVY (Drug) $193.11
- VRAYLAR (Drug) $110.97
- BELSOMRA (Drug) $73.58
- Ozempic (Drug) $70.70
- QULIPTA (Drug) $65.25
- Dayvigo (Drug) $59.22
- Zubsolv (Drug) $47.43
- NURTEC ODT (Drug) $43.65
- FARXIGA (Drug) $42.82
- ADHANSIA XR (Drug) $31.89
- TRELEGY ELLIPTA (Drug) $31.81
- MYRBETRIQ (Drug) $29.84
- TROKENDI XR (Drug) $29.54
- Myrbetriq (Drug) $28.66
- XARELTO (Drug) $26.24
- CHANTIX (Drug) $26.21
- ABILIFY MAINTENA (Drug) $23.45
- ELIQUIS (Drug) $23.04
- QUVIVIQ (Drug) $22.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lake Worth
Elizabeth Gunther, D.o, D.O
Family Medicine — Payments: $12,014
Rafael Ubeda, Md, MD
Family Medicine — Payments: $4,997
Dr. David Simon, Do, DO
Family Medicine — Payments: $4,545
Antonella Berger, Arnp, ARNP
Family Medicine — Payments: $1,441
Ms. Shelly Kramer, Arnp, ARNP
Family Medicine — Payments: $1,022
Jennifer Nguyen, Do, DO
Family Medicine — Payments: $892.90